Mexico Diabetes Treatment raises hopes for Millions

March 17, 2011 - PRLog -- Innovative stem cell treatment raises genuine hope for millions of  Diabetes suffers

Puerto Vallarta, Mexico (February 25, 2011) - Diabetes Type II is a chronic condition that affects the way the body metabolizes sugar. Currently there are approximately 20 million diagnosed with diabetes type 2 in the U.S., in addition to that, there are approximately  7 million undiagnosed, as well as 60 million pre-diabetic cases, 1.6 million new cases of diabetes are diagnosed in people aged 20 years and older each year.

Finally, there is a real hope for millions of people living with this condition. Regenerative medicine offers a complete new treatment approach to this pandemic issue.
The Institute of Biomedical Research (IIB), under the supervision of Dr. Raul Morales, has been successfully treating patients with diabetes through adult autologous stem cell transplant. Unlike current conventional medicine methods, stem cell transplant inhibits insulin resistance, decreases inflammatory response, initiates new insulin producing cells in the pancreas and fights secondary complications.

Furthermore, IIB’s state of the art regenerative medicine approach initiates an immunomodulation process to prevent the formation of auto-antibodies, stabilizes the body’s ability to use insulin adequately thus creating a healthy environment for the body to metabolize blood sugar. The purpose of the treatment is to reduce/eliminate the patient’s dependency on exogenous insulin.

Dr. Morales and his team of regenerative medicine specialists continue to prove that scientific based medicine is a better approach for providing solutions to  millions of diabetes sufferers.

IIB offers its services in beautiful Puerto Vallarta, Mexico. For more information, contact IIB toll free at 1-877-219-1289 or visit www.iibmed.com.

http://www.iibmed.com